This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

How many weeks away will the next news be?

MS

Just woke up this great news! well done Goldfinger just the tonic i needed.My portfolio needed some medication !!!
DB66

Weeks I thought it was days Mickey. Well take Easter weekend holiday away and it will.

cheers GF.

Bring it on baby.

I feel a pint coming on.

MS

Me too.

cheers GF.

hi guy's, just got in from work.

Phoned my pal from work today and asked him to check the sp for me... down 4.5%...... bugger...........just got home and seen the close price
Well done to everybody who has held their nerve
A happy rob!

How far do we think it could go from here?

Looks like these are up next for clinical trials.............

All of our lead ruthenium compounds appear to be more active than
carboplatin, and many of them are more active than cisplatin, the most active
platinum-based drug. With this study complete we are now working with our chosen
CRO to finalise the pre-clinical testing stage with the aim of entering clinical
trials with three ruthenium products as soon as possible.

Someone on this thread I think mentioned early April.

When Mitzy gets back from the shop he will probably know.

cheers GF.

Comments from MW caused the push through 188p and upto 202p

M;
Whats he said...?

So all out in the pub?Congratulations,your adventure has kept me absorbed for days.Good on ya..you kept the faith.
Goldfinger deserves a knighthood.
You all deserve every penny you make.That took courage!!

In a nut shell Mitzy BUY BUY then BUY some more. Looks like we could see 3 by Friday.

We could be looking at a 10 bagger within 12 months.

thanks mom.. also I notice he has since added a new thread..."why MMI is a world beater"...he sure must like this stock..by the way market closed Friday.!

227p close tomorrow.and 270p the next day.

Gosh I wish we could get that info from his site. Anyone out there with a copy???????????????????????????????????????.

cheers GF.

Apologies, for my ignorance but who is MW ?

Mike Walters as gone ballistic over on his board tonight about MMG, Ive never seen him so brimming with passion. Heres the headlines, two articles in one evening unheard of.................................


A World-Beater?
22/3/2005

Medical Marketing is involved in a remarkable breakthrough.
[Read more]

AND

Do Not Sell MMG
22/3/2005

Dramatic news from Medical Marketing.

cheers GF.

Anyone a member of advfn, would they please paste the above news on there, might stop some 'get rich quick merchants' from selling way way too early.

Cheers GF.

Back to top for Hustler.
cheers GF.

Goldfinger if you wish to read the articles written by M Walters then subscribe to his site. At 75 per annum, it is well worth the fee. Excellent site.